BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Gilead Sciences, Inc. 

333 Lakeside Drive

Foster City  California  94404  U.S.A.
Phone: 800-GILEAD-5 or 650-574-3000 Fax: 650-522-5800


SEARCH JOBS




Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need.The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.


 Key Statistics


Email:
Ownership: Public

Web Site: Gilead Sciences, Inc.
Employees: 4,000
Symbol: GILD
 



Industry
Biotechnology






 Company News
Gilead Sciences, Inc. (GILD) To Release Third Quarter 2014 Financial Results On Tuesday, October 28, 2014 10/22/2014 9:40:49 AM
Gilead Sciences, Inc. (GILD)'s $1,000-A-Pill Hepatitis C Drug May Make Financial Sense For Prisons 10/20/2014 7:33:06 PM
Gilead Sciences, Inc. (GILD) To Create More Than 80 Jobs With $50 Million Expansion 10/20/2014 7:30:46 PM
Health Canada Issues Notice Of Compliance For Gilead Sciences, Inc. (GILD)'s Harvoni™ (ledipasvir/sofosbuvir), The First Once-Daily Single Tablet Regimen For The Treatment Of Genotype 1 Chronic Hepatitis C 10/17/2014 7:14:37 AM
UBS: Gilead Sciences, Inc. (GILD) Remains Solid Buy Despite Irish Tax Changes, Price War 10/15/2014 12:56:35 PM
Gilead Sciences, Inc. (GILD) Nervous As Johnson & Johnson (JNJ) Looks To Remain Competitive In Hepatitis C Market 10/15/2014 6:04:15 AM
Analysts: Harvoni News Nothing But Upside For Gilead Sciences, Inc. (GILD) 10/13/2014 12:48:58 PM
FDA Approves Gilead Sciences, Inc. (GILD)'s New Hepatitis C Drug Harvoni 10/10/2014 4:19:34 PM
Gilead Sciences, Inc. (GILD) Will Have Higher Revenues, EPS On Liver Drug Strength: Citi 10/9/2014 1:44:48 PM
Gilead Sciences, Inc. (GILD)'s Solvadi May Be Barred From UK's Service Plan 10/8/2014 6:42:57 AM
12345678910...